Cat.#: ASSD-131
| Description | Fluorescent metal ion indicator. Exhibits resistance to alkaline hydrolysis and displays similar calcium-binding properties to calcein. It fluoresces in both acidic and basic solutions when excited by the correct wavelength. Enhanced fluorescence is shown when bound to Ca (II), La (II) and Zn (II). Reduced fluorescence is shown when bound to Fe (II), Cu (II), Ni (II), Mn (II) and Co (II). |
| Size | 1 mg |
| Molecule Weight | 321.28 |
| Molecular formula | C15H15NO7 |
| CAS Number | 54375-47-2 |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-134 | FITC Phalloidin (AC134) | 300 tests, 100μg | inquiry |
| ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg | inquiry |
| ASSD-176 | Rhodamine B isothiocyanate (AC176) | 100 mg, 500 mg | inquiry |
| ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg | inquiry |
| ASSD-113 | Thionin acetate salt (AC113) | 5 g | inquiry |
| ASSD-183 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) | 100 mg | inquiry |
| ASSD-215 | 1-Pyrenylmethyl Methanethiosulfonate (AC215) | 10 mg | inquiry |
| ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg | inquiry |
| ASSD-137 | CCR2 covalent NAM (AC137) | 50 μg | inquiry |
| ASSD-175 | 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) | 25 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.